Home / Health / UK Babies to Be Screened for Deadly SMA at Birth
UK Babies to Be Screened for Deadly SMA at Birth
1 Oct
Summary
- NHS begins nationwide SMA screening for newborns starting today.
- Trial aims to detect spinal muscular atrophy at birth for early treatment.
- Screening rollout aims to prevent lifelong anguish for dozens of families annually.
Newborns in England will now be screened for spinal muscular atrophy (SMA) as a significant pilot program launches today. This initiative, driven by the advocacy of singer Jesy Nelson whose daughters were diagnosed too late for effective treatment, aims to detect SMA at birth. By identifying the genetic disorder early, healthcare professionals hope to enable timely treatment, potentially saving dozens of families each year from the severe impact of SMA.
The screening utilizes blood samples already collected for routine newborn testing. While Scotland already screens for SMA, this expansion in England is being closely evaluated. Clinics in Birmingham are the first to implement the test, with Manchester to follow. The program is expected to reach all hospitals in England by spring 2028, ensuring comprehensive coverage.
Experts anticipate this evaluation will provide crucial data for the UK National Screening Committee to decide on permanent inclusion of SMA screening in the national blood spot test. Novartis, a manufacturer of an SMA treatment, anticipates a wider expansion to all newborns in England by October 2027. This proactive approach signifies a major advancement in pediatric healthcare and offers renewed hope for affected families.
